People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Samsung is recognizing Española Valley High School for its student’s efforts to help people dealing with Parkinson’s Disease.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

Ozzy Osbourne has been battling a rare form of Parkinson's Disease known as Parkin 2. In 2020, he disclosed to his fans that ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...